Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands

  • 1,
  • 2,
  • 3,
  • 4,
  • 4,
  • 5,
  • 5,
  • 6,
  • 7,
  • 8,
  • 9,
  • 10,
  • 5,
  • 11 and
  • 11, 12Email author
BMC Pulmonary MedicineBMC series – open, inclusive and trusted201616:105

https://doi.org/10.1186/s12890-016-0270-9

  • Received: 20 May 2016
  • Accepted: 19 July 2016
  • Published:

The original article was published in BMC Pulmonary Medicine 2016 16:80

Erratum

The original version of this article [1] unfortunately contained errors that have since been corrected.

The word “pharmo” has been fully capitalised to “PHARMO” throughout the article.

The reference to Table 2 in the first and second sentence under the Outcomes heading has been replaced with Fig. 3.

Under the Abbreviations heading ‘extrafine-particle’ was repeated, this has been corrected to ‘EF-HFA-BDP [Qvar®]: extrafine-particle hydrofluoroalkane beclomethasone dipropionate’.

The competing interests of Nicolas Roche and Theresa Guibert have been amended.

Academic affiliations for Dirkje S. Postma (2), Richard J. Martin (3), Ron M.C. Herrings (4), Jetty Overbeek (4), and Nicolas Roche (7) have been corrected.

Figure 3 in the online and pdf version did not match, this been amended.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of General Practice, University of Groningen, University Medical Center, Groningen, The Netherlands
(2)
University of Groningen, University Medical Center Groningen, Department Pulmonary Medicine and Tuberculosis, Groningen, The Netherlands
(3)
National Jewish Health and the University of Colorado, Denver, USA
(4)
PHARMO Institute for Drugs Outcome Research, Utrecht, The Netherlands
(5)
Research in Real Life, Ltd, Cambridge, UK
(6)
Radboud University Medical Centre, Nijmegen, The Netherlands
(7)
Groupe Hospitalier Cochin, AP-HP and University Paris Descartes (EA2511), Paris, France
(8)
Cincinnati Children’s Hospital and Medical Center, Cincinnati, USA
(9)
Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
(10)
Emma’s Children Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
(11)
Observational & Pragmatic Research Institute Pte, Ltd, Singapore, Singapore
(12)
Academic Primary Care, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK

References

  1. van der Molen T, et al. BMC Pulm Med. 2016;16:80. doi:10.1186/s12890-016-0234-0.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement